Cancer Incidence and Mortality for All Sites of Cancer, Monroe County, 2010-2014

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2150.4 549.1 10.6 2198.0 462.0 8.9 753.6 198.1 6.5 759.6 147.2 4.8
Oral cavity and pharynx
All Oral cavity and pharynx 63.6 15.7 1.8 36.4 7.3 1.1 11.6 2.9 0.8 10.0 1.9 0.5
Lip 2.4 0.6 0.4 2.4 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0
Tongue 19.8 5.0 1.0 11.2 2.2 0.6 2.8 0.7 0.4 3.4 0.7 0.3
Salivary gland 5.2 1.3 0.5 4.6 1.0 0.4 0.6 0.2 0.2 2.2 0.4 0.2
Floor of mouth 4.2 1.1 0.5 1.8 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Gum & other mouth 7.6 1.9 0.6 9.4 1.9 0.6 1.2 0.3 0.2 1.4 0.2 0.2
Nasopharynx 1.0 0.2 0.2 0.4 0.1 0.1 0.6 0.2 0.2 0.4 0.1 0.1
Tonsil 13.2 3.2 0.8 3.4 0.7 0.3 1.6 0.4 0.3 0.6 0.1 0.1
Oropharynx 4.2 0.9 0.4 1.2 0.2 0.2 2.4 0.6 0.3 1.2 0.2 0.2
Hypopharynx 5.0 1.2 0.5 1.8 0.4 0.2 0.8 0.2 0.2 0.2 0.0 0.1
Other buccal cavity and pharynx 1.0 0.2 0.2 0.2 0.0 0.1 1.0 0.2 0.2 0.6 0.1 0.1
Digestive system
All Digestive system 383.6 97.2 4.5 327.0 65.4 3.3 208.6 53.8 3.3 173.4 32.3 2.2
Esophagus 32.8 8.2 1.3 10.4 1.9 0.5 33.8 8.7 1.3 9.4 1.7 0.5
Stomach 40.6 10.6 1.5 21.8 4.4 0.8 18.2 4.9 1.0 10.8 2.2 0.6
Small intestine 14.8 3.7 0.9 12.0 2.7 0.7 2.8 0.8 0.4 3.0 0.6 0.3
Colorectal 162.4 41.6 2.9 174.2 34.8 2.4 55.6 14.6 1.8 66.6 12.2 1.4
Colon excluding rectum 100.8 26.1 2.3 129.6 25.3 2.0 43.0 11.4 1.6 57.2 10.4 1.3
Cecum 21.8 5.8 1.1 32.8 6.2 1.0            
Appendix 6.4 1.7 0.6 6.0 1.3 0.5            
Ascending colon 16.6 4.3 0.9 27.8 5.3 0.9            
Hepatic flexure 4.0 1.0 0.5 5.2 1.0 0.4            
Transverse colon 10.0 2.6 0.7 11.0 2.0 0.6            
Splenic flexure 4.6 1.1 0.5 4.6 0.9 0.4            
Descending colon 6.4 1.7 0.6 6.2 1.3 0.5            
Sigmoid colon 24.8 6.3 1.1 27.6 5.8 1.0            
Large intestine, NOS 6.2 1.7 0.6 8.4 1.5 0.5            
Rectum & rectosigmoid 61.6 15.4 1.8 44.6 9.5 1.3 12.6 3.2 0.8 9.4 1.9 0.6
Rectosigmoid junction 13.4 3.5 0.9 11.6 2.5 0.7            
Rectum 48.2 11.9 1.5 33.0 7.1 1.1            
Anus, anal canal & anorectum 6.6 1.6 0.5 8.6 1.7 0.5 2.4 0.6 0.3 1.4 0.3 0.2
Liver and intrahepatic bile duct 45.6 11.0 1.5 17.4 3.6 0.8 34.0 8.4 1.3 19.8 3.8 0.8
Liver 40.4 9.6 1.4 12.8 2.6 0.7 25.2 6.1 1.1 10.6 2.1 0.6
Intrahepatic bile duct 5.2 1.4 0.5 4.6 0.9 0.4 8.8 2.3 0.7 9.2 1.7 0.5
Gallbladder 1.6 0.5 0.3 3.6 0.8 0.4 0.6 0.2 0.2 2.0 0.4 0.2
Other biliary 9.6 2.3 0.7 9.4 1.9 0.6 2.0 0.5 0.3 1.4 0.3 0.2
Pancreas 63.2 16.1 1.8 60.8 11.7 1.4 56.6 14.5 1.7 54.4 10.0 1.2
Retroperitoneum 2.4 0.6 0.3 2.6 0.6 0.4 0.2 0.1 0.1 0.6 0.1 0.1
Peritoneum, omentum & mesentery 0.4 0.1 0.1 4.0 0.8 0.4 0.6 0.1 0.1 1.4 0.3 0.2
Other digestive organs 3.6 0.9 0.4 2.2 0.4 0.3 1.8 0.4 0.3 2.6 0.5 0.3
Respiratory system
All Respiratory system 307.4 79.6 4.1 293.8 58.8 3.1 226.6 59.1 3.5 194.8 38.7 2.5
Nasal cavity, middle ear & sinuses 3.2 0.8 0.4 4.6 0.9 0.4 0.4 0.1 0.2 0.8 0.1 0.1
Larynx 23.4 5.8 1.1 4.6 0.9 0.4 10.0 2.6 0.7 3.2 0.6 0.3
Lung and bronchus 280.0 72.6 3.9 283.8 56.8 3.0 215.4 56.1 3.4 190.4 37.9 2.5
Pleura 0.4 0.1 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 0.4 0.1 0.2 0.8 0.2 0.2 0.4 0.1 0.2 0.4 0.1 0.1
Soft tissue, bone, and skin
Bones & joints 4.0 1.1 0.5 4.4 1.2 0.5 1.8 0.4 0.3 1.4 0.3 0.2
Soft tissue (including heart) 17.4 4.5 1.0 13.8 3.3 0.8 5.6 1.5 0.6 7.2 1.5 0.5
Skin~ 123.8 32.8 2.6 106.4 24.6 2.2 18.6 5.1 1.0 12.6 2.3 0.6
Melanoma of the skin 110.6 29.1 2.5 99.8 23.3 2.1 11.8 3.2 0.8 9.2 1.7 0.5
Breast
Breast 5.6 1.4 0.5 660.6 142.4 5.0 0.8 0.2 0.2 101.8 20.0 1.8
Female genital system
All Female genital system       260.4 54.1 3.0       90.6 17.9 1.7
Cervix uteri       26.6 6.3 1.1       11.0 2.5 0.7
Corpus uterus and NOS       152.4 30.9 2.2       29.0 5.6 0.9
Ovary       56.4 11.8 1.4       44.6 8.8 1.2
Vagina       1.2 0.2 0.2       0.6 0.1 0.1
Vulva       15.8 3.1 0.7       2.4 0.4 0.2
Other female genital organs       8.0 1.6 0.5       3.0 0.5 0.3
Male genital system
All Male genital system 586.0 143.6 5.3       68.8 18.8 2.0      
Prostate 564.6 137.3 5.2       67.6 18.5 2.0      
Testis 18.8 5.6 1.2       0.6 0.1 0.2      
Penis 2.4 0.7 0.4       0.4 0.1 0.2      
Other male genital organs 0.2 0.0 0.1       0.2 0.1 0.1      
Urinary system
All Urinary system 267.8 70.6 3.9 109.6 22.3 1.9 54.2 14.5 1.8 20.4 3.6 0.7
Urinary bladder (including in situ) 162.6 43.5 3.0 51.2 10.0 1.3 31.4 8.6 1.4 8.8 1.4 0.4
Kidney and renal pelvis 99.4 25.5 2.3 57.2 12.1 1.4 21.6 5.6 1.1 11.2 2.1 0.6
Ureter 2.2 0.5 0.3 0.4 0.1 0.1 0.6 0.1 0.2 0.0 0.0 0.0
Other urinary organs 3.6 1.0 0.5 0.8 0.2 0.2 0.6 0.2 0.2 0.4 0.1 0.1
Eye & orbit
Eye & orbit 2.2 0.5 0.3 1.4 0.3 0.2 0.0 0.0 0.0 0.4 0.1 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 58.6 15.0 1.8 92.4 20.3 1.9 21.8 5.8 1.1 21.8 4.7 0.9
Malignant brain / other nervous system 24.2 6.4 1.2 26.8 6.5 1.1 18.0 4.7 1.0 18.2 4.0 0.8
Malignant brain 22.4 5.9 1.1 24.6 6.0 1.1            
Malignant other nervous system 1.8 0.5 0.3 2.2 0.6 0.3            
Benign brain / other nervous system* 34.4 8.6 1.3 65.6 13.8 1.6 3.8 1.0 0.5 3.6 0.7 0.3
Benign brain 2.4 0.6 0.3 3.8 0.9 0.4            
Benign other nervous system 32.0 8.0 1.3 61.8 12.9 1.5            
Endocrine system
All Endocrine system 36.8 9.5 1.4 81.4 20.0 2.0 2.4 0.6 0.4 4.8 0.9 0.4
Thyroid 33.2 8.6 1.3 78.2 19.2 2.0 1.8 0.4 0.3 3.6 0.6 0.3
Other endocrine (including thymus) 3.6 1.0 0.5 3.2 0.8 0.4 0.6 0.2 0.2 1.2 0.3 0.2
Lymphomas
All Lymphomas 114.2 29.9 2.5 100.0 20.9 1.9 27.4 7.4 1.3 23.8 4.5 0.8
Hodgkin lymphoma 13.2 3.5 0.9 13.8 3.4 0.8 0.8 0.2 0.2 1.2 0.2 0.2
Non-Hodgkin lymphomas 101.0 26.4 2.4 86.2 17.5 1.7 26.6 7.2 1.2 22.6 4.2 0.8
Myeloma
All Myeloma 35.4 9.0 1.4 26.4 5.2 0.9 19.8 5.2 1.0 13.4 2.5 0.6
Leukemias
All Leukemias 83.2 21.9 2.1 66.2 14.0 1.6 37.0 9.9 1.4 33.0 6.4 1.0
Lymphocytic leukemias 46.2 12.0 1.6 32.4 6.8 1.1 10.4 2.7 0.7 9.0 1.6 0.5
Acute lymphocytic leukemia 4.6 1.3 0.5 3.6 0.9 0.4 1.2 0.3 0.3 2.2 0.5 0.3
Chronic lymphocytic leukemia 38.2 9.8 1.4 26.0 5.3 0.9 9.0 2.3 0.7 6.0 1.0 0.4
Other lymphocytic leukemias 3.4 0.9 0.4 2.8 0.6 0.3 0.2 0.0 0.1 0.8 0.1 0.1
Myeloid and monocytic leukemias 34.2 9.1 1.4 31.8 6.8 1.1 18.8 5.1 1.1 20.0 3.9 0.8
Acute myeloid leukemia 21.4 5.7 1.1 22.6 4.8 0.9 17.4 4.7 1.0 17.8 3.5 0.8
Acute monocytic leukemia 1.2 0.3 0.2 1.6 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1
Chronic myeloid leukemia 10.4 2.8 0.8 6.4 1.3 0.5 0.8 0.2 0.2 1.2 0.2 0.2
Other myeloid/monocytic leukemias 1.2 0.4 0.3 1.2 0.3 0.3 0.6 0.2 0.2 0.8 0.2 0.2
Other leukemias 2.8 0.8 0.4 2.0 0.4 0.3 7.8 2.1 0.7 4.0 0.9 0.4
Other acute leukemias 1.0 0.3 0.2 0.8 0.2 0.2 4.4 1.2 0.5 1.8 0.4 0.2
Aleukemic, subacute, leukemia NOS 1.8 0.5 0.3 1.2 0.2 0.2 3.4 0.9 0.4 2.2 0.5 0.3
Mesothelioma
Mesothelioma 5.4 1.5 0.6 1.0 0.2 0.2            
Kaposi sarcoma
Kaposi sarcoma 2.6 0.7 0.4 0.2 0.0 0.0            
Myelodysplastic syndromes
Myelodysplastic syndromes 31.0 8.5 1.4 22.8 4.1 0.8            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 15.4 4.1 0.9 18.8 3.9 0.8            
Ill defined and unspecified sites
Ill defined and unspecified sites 40.8 10.6 1.5 40.6 7.6 1.1 52.4 14.0 1.7 53.8 10.4 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2016.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.